Efficacy of circulating plasma DNA as a diagnostic tool for advanced non-small cell lung cancer and its predictive utility for survival and response to chemotherapy
Authors:
- Sachin KumarSKSachin Kumar
- Randeep GuleriaRGRandeep Guleria
- Vikas SinghVSVikas Singh
- Alok C. BhartiABAlok C. Bharti
- Anant MohanAMAnant Mohan
- Bhudev C. DasBDBhudev C. Das
- 1 November 2010
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 70 (2) , 211-217
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Personalized Medicine and Inhibition ofEGFRSignaling in Lung CancerNew England Journal of Medicine, 2009
- The New Lung Cancer Staging SystemChest, 2009
- Comparison of Circulating Plasma DNA Levels between Lung Cancer Patients and Healthy ControlsThe Journal of Molecular Diagnostics, 2009
- Plasma DNA Quantification in Lung Cancer Computed Tomography ScreeningAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancerLung Cancer, 2009
- Tobacco smoking and chewing, alcohol drinking and lung cancer risk among men in southern IndiaInternational Journal of Cancer, 2003
- Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year resultsThe Lancet, 2003
- Plasma DNA microsatellite panel as sensitive and tumor‐specific marker in lung cancer patientsInternational Journal of Cancer, 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 1999